TrialCancer science2021

IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients.

Makoto Nishio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.